Replies to post #136473 on PharmaCyte Biotech Inc (PMCB)

[efood125]

Funny thing is those that say they are out continue to stay around and pound...what's up with that!

[ClarkKant]

I have no skin in the game here and do not know the history of PMCB, but I follow a lot of bios.

On the surface, the news does not seem like -50% move is warranted. If the time frame is what is in question now and nothing else, a -50% move down is an overreaction. It's acting like they just did a 200:1 RS announcement.

JMO, GLTA.

[$Pistol Pete$]

Wrong.....multiple preclinical studies needed and multiple and multiple data and especially multiple dumping shares will happen here

REVERSE SPLIT on the way

[DragonBear]

Its all about safety issues-wrong

and that will be addressed.

I see nowhere in the Kenny PR pump where he states: "It's all about safety issues, that will be addressed". It's a lot more than that.

Neither does he state, everything will be addressed in 1 month or overnight.

Since the FDA’s letter included a lengthy list of items and several preclinical studies, at this time it’s impossible to say when the company will be in a position to submit a complete response to the FDA

That's an open ended indeterminant time line. Reset things back to Jan 2018. Kenny will be PR pumping away about "tests"... again. That should be good for 2 yrs. Blame lack of progress during the time on Covid. Time for another 1B or so shares of dilution starting 3-6 months from now. Yeah retail SHs will have ample opportunity to buy those cheap 0.005, and below shares from the 3rd parties.